Loading...
You are here://Janssen first clinical trial
Janssen first clinical trial 2018-06-07T10:18:48+00:00

Janssen FIRST Clinical Trial

A STUDY OF PSYCHOEDUCATION AND SKILLS TRAINING

The main purpose of this study is to see if psycho-education and skills training provided over a 6 month time period may benefit a patient’s caregiver, which may then overall benefit the patient.

“FIRST” is an acronym, which stands for: Family Intervention in Recent Onset Schizophrenia Treatment.

What is the role of MyHealios in the study?

MyHealios clinicians provide an evidence-based psychoeducation and skills training program to caregivers participating in the study.

What are the benefits of being in the study?

There is no medical benefit to you by being in this study. It is unknown whether there is any benefit to you by participating in the psychoeducation and skills training sessions. By taking part, you may help future patients and caregivers of schizophrenia patients.

What are the possible risks and inconveniences of being in the observational study?

There are no tests that cause pain or discomfort or physical risks performed while enrolled in this observational study.

What qualifications do MyHealios staff have?

MyHealios clinicians have Master’s degrees in Social Work. MyHealios provides their clinicians with ongoing training and regular supervision by MyHealios’ Consultant Clinical Psychologist and Consultant Psychiatrist.

Legal Information

Back to Research Studies